Related Experiment Video
Updated: Jul 5, 2026
14:25
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
Plasma lipid profile in gynecologic cancers
1Department of Biochemistry, Faculty of Biological Sciences, Quiad-i-Azam University, Islamabad, Pakistan. mrimranqadir@hotmail.com
European Journal of Gynaecological Oncology
|May 8, 2008
Summary
Plasma lipid profiles differ in gynecologic cancers. Breast cancer shows elevated lipids, while ovarian and other gynecologic cancers exhibit decreased levels, except for HDL-cholesterol which is reduced in all cancer types.
Area of Science:
- Biochemistry
- Oncology
- Clinical Diagnostics
Background:
- Lipids are crucial for cell integrity and are implicated in cancer development.
- Altered lipid metabolism is a known hallmark of various cancers.
- This study investigates the specific relationship between plasma lipid profiles and gynecologic malignancies.
Purpose of the Study:
- To analyze plasma lipid levels in patients with breast, ovarian, and other gynecologic cancers.
- To compare lipid profiles (triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol) against healthy controls.
- To determine the potential diagnostic utility of plasma lipid alterations in gynecologic cancers.
Main Methods:
- Spectrophotometric analysis of plasma lipid concentrations.
- Inclusion of 196 female participants: 50 healthy controls and 146 cancer patients (80 breast, 40 ovarian, 26 other gynecologic cancers).
- Quantification of plasma triglycerides, total cholesterol, LDL-cholesterol, and HDL-cholesterol.
Main Results:
- Breast cancer patients showed increased triglycerides (18%), cholesterol (21%), and LDL-cholesterol (43%), with decreased HDL-cholesterol (30%).
- Ovarian cancer patients exhibited decreased triglycerides (31%), cholesterol (28%), LDL-cholesterol (11%), and HDL-cholesterol (39%).
- Other gynecologic cancers displayed decreased triglycerides (25%), cholesterol (21%), and HDL-cholesterol (27%), with a non-significant decrease in LDL-cholesterol (6.2%).
Conclusions:
- Plasma lipid profiles are significantly altered in gynecologic cancers.
- Elevated lipids (except HDL-cholesterol) are observed in breast cancer, while decreased levels are seen in other gynecologic cancers.
- Reduced HDL-cholesterol is a consistent finding across all studied gynecologic cancer types, suggesting potential diagnostic value.
Related Concept Videos
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...